Abstract:Some studies showed a "rejuvenating" effect of exposing aging tissues to a young environment. In mouse heterochronic parabiosis experiments, in response to young organisms, old animals lived longer than isochrony old age-matched conjoint animals. Comparable "rejuvenating" effects were obtained by injecting young plasma in old mice. This raised great hopes of slowing down the senescence process in humans by the injection of young plasma, as well as to prevent or cure age-related diseases. Some clinical trials are currently being performed or were recently completed. However, these studies are small and of limited duration, and we still lack convincing evidence to support the effectiveness of young plasma injection. It is urgent to perform additional investigations, including the development of an assay to measure the cell proliferation induction capability of different human plasmas, before one can seriously think of a large-scale treatment of humans. We adopted a simple method to measure the potential of different plasmas in supporting cell line proliferation, regardless of the co-presence of a platelet lysate. By comparing plasmas from young and old subjects, we observed a decreased activity in plasmas from old individuals. The young plasma effect may be attributed to specific proteins and growth factors more abundant in younger individuals that could decrease with age. Alternatively, or at the same time, the reduced cell proliferation support could be due to inhibitors present in the old plasma. Studying the different protein content of young and old plasmas was out of the scope of this article. Such differences should be adequately investigated by proteomics using many samples. However, a preliminary study of the different protein content of young and old plasmas was part of the assay validation using a commercially available cytokine array for parallel determination of the relative levels of 105 selected human proteins. We could show the existence of specific differences between young and old plasmas and that plasmas from old individuals presented a higher concentration of "inflammatory" proteins.

Young plasma reverses age-dependent alterations in hepatic function through the restoration of autophagy.

Young plasma attenuates age‐dependent liver ischemia reperfusion injury

Young blood plasma reduces Alzheimer’s disease-like brain pathologies and ameliorates cognitive impairment in 3×Tg-AD mice

Young plasma reverses anesthesia and surgery-induced cognitive impairment in aged rats by modulating hippocampal synaptic plasticity

The rejuvenating influence of young plasma on aged intestine

Young Plasma Attenuated Chronic Kidney Disease Progression after Acute Kidney Injury by Inhibiting Inflammation in Mice

Small Extracellular Vesicles from Young Plasma Reverse Age-Related Functional Declines by Improving Mitochondrial Energy Metabolism

Neural Correlates of Beneficial Effects of Young Plasma Treatment in Aged Mice: PET-SPM Analyses and Neuro-Behavioural/molecular Biological Studies

The effect of young blood plasma administration on gut microbiota in middle-aged rats

Rejuvenation of young blood on aging organs: Effects, circulating factors, and mechanisms

Age-related differences in response to plasma exchange in male rat liver tissues: insights from histopathological and machine-learning assisted spectrochemical analyses

Reversal of Biological Age in Multiple Rat Organs by Young Porcine Plasma Fraction

Young Blood Plasma Administration to Fight Alzheimer's Disease?

Aged-related Function Disorder of Liver is Reversed after Exposing to Young Milieu <i>via</i> Conversion of Hepatocyte Ploidy

Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin

Rejuvenating the blood and bone marrow to slow aging-associated cognitive decline and Alzheimer’s disease

Aging Systemic Milieu Impairs Outcome after Ischemic Stroke in Rats

A simple cell proliferation assay and the inflammatory protein content show significant differences in human plasmas from young and old subjects

Plasma dilution improves cognition and attenuates neuroinflammation in old mice

Blood autophagy defect causes accelerated non-hematopoietic organ aging.